Submissions

Original Articles

• This is a report of a formal basic science or clinical research study.
• Manuscripts reporting unique scientific studies should be no longer than 5000 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends). A maximum of 50 references can be included.
• Manuscripts should consist of the following sections:
  • Introduction: This should concisely present the background to the problem that the study hopes to answer. An aim should be clearly stated at the end of the introduction.
  • Methods: This section should be suitably detailed to permit replication of the study. Subheadings may be useful in this section to help clarify the content in longer papers.

For established methods, appropriate references and a brief description are sufficient; but for new methods, appropriate details are required.

For human studies, where relevant, these details are generally important: eligibility (inclusion and exclusion criteria), randomization methods, blinding methods, total consecutive patients enrolled, and number of exclusions or dropouts and reasons. The regulatory permissions for the study should also be detailed, e.g. Institutional Review Board, ethical committee etc, including a protocol/registration number.

Where animal research has been undertaken, the institutional animal care and use guidelines that have been followed should be clearly stated.

• Results: These should involve the reporting of the salient positive and negative findings of the study in clear language. The use of images, figures and tables are encouraged, of which the data should not be duplicated in the prose. There is no maximum number of figures or tables, but these should be appropriate to the study. Numerical results and P values should be reported to three decimal places.
• Discussion: This should place the reported study findings in the context of the literature. Limitations and future direction should also be discussed. Authors must be careful to ensure that conclusions are not overstated and are supported by data.
• Conclusion: This section should concisely conclude the findings of your study.
• Original articles should contain a structured abstract with a maximum of 250 words.
• We recommend authors to use the appropriate Reporting Guideline (https://www.equator-network.org/) for their study. If any checklists are used, they should be included during submission.

Narrative Review Articles

• This style of article can afford the author considerable latitude in examining a pertinent topic in endovascular hemorrhage control. The literature should be examined objectively and presented to the reader in the context of current understanding. The author should be able to synthesize a narrative, which leaves the reader with a good understanding of an emerging or controversial topic. The author is welcome (and encouraged) to express an opinion, but where this is the case, it should be clearly stated.
• The submitted manuscript should be no longer than 5000 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends). A maximum of 125 references can be included.
• There is no formal structure; however, the use of logical headings/sub-headings is important to enable readers to follow the article easily.
• The abstract should also be unstructured and be a maximum of 150 words.

Systemic Reviews and Meta-Analyses

• Where there is a topic within the subject area of endovascular hemorrhage control that has a substantial evidence base, a Systematic Review with/without a Meta-Analysis is considered more appropriate than a narrative review article. These articles should follow the methodology established by PRISMA. The overall aim is to provide a pooled analysis that enables firm conclusions to be drawn on a particular subject.
• Submitted manuscripts should be no longer than 5000 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends). A maximum of 125 references can be included.
• Manuscripts should consist of the following sections:
  • Introduction: This should concisely present the background to the problem that the study hopes to answer. An aim should be clearly stated at the end of the introduction.
  • Methods: This section should be suitably detailed to permit replication of the study. Subheadings may be useful in this section to help clarify the content in longer papers. For established methods, appropriate references and a brief description are sufficient; but for new methods, appropriate details are required. The complete search strategy, if long, could preferably be included as a supplementary digital table, rather than text directly under the method section.
  • Results: These should involve the reporting of the salient positive and negative findings of the study in clear language. The use of images, figures and tables are encouraged, of which the data should not be duplicated in the prose. There is no maximum number of figures or tables, but these should be appropriate to the study. Numerical results and P values should be reported to three decimal places.
  • Discussion: This should place the reported study findings in the context of the literature. Limitations and future direction should also be discussed. Authors must be careful to ensure that conclusions are not overstated and are supported by data.
  • Conclusion: This section should concisely conclude the findings of your study.
• Authors should include a PRISMA checklist in their submission.
• The abstract should be a maximum of 250 words.

Tips and Techniques

• In the evolving world of endovascular hemorrhage control, the advice and opinion of actively practicing clinicians is of great importance. Both solicited and unsolicited submissions are reviewed, both on major and minor components of endovascular techniques. This can be presented in the context of “evidence” or just as an opinion. The use of quality images and diagrams is encouraged. This type of article permits the author to write from experience, rather than from the published literature. Articles explaining how to approach certain problems or how to accomplish certain maneuvers are welcomed.
• The submitted manuscript should be no longer than 1500 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends). A maximum of 30 references can be included.
• Manuscripts should consist of the following sections:
  • Introduction: This should concisely present the background to the problem that the study hopes to answer. An aim should be clearly stated at the end of the introduction.
  • Methods: This section should be suitably detailed to permit replication of the study. Subheadings may be useful in this section to help clarify the content in longer papers.
  • Results: These should involve the reporting of the salient positive and negative findings of the study in clear language. The use of images, figures and tables are encouraged, of which the data should not be duplicated in the prose. There is no maximum number of figures or tables, but these should be appropriate to the study. Numerical results and P values should be reported to three decimal places.
  • Discussion: This should place the reported study findings in the context of the literature. Limitations and future direction should also be discussed. Authors must be careful to ensure that conclusions are not overstated and are supported by data.
  • Conclusion: This section should concisely conclude the findings of your study.
• The abstract should be unstructured and be a maximum of 150 words.

Images of Interest

• The Journal accepts images of interest accompanied by a short commentary. The aim of this section is to demonstrate and illustrate an educational message, rather than just to demonstrate dramatic pathology. Images can be submitted as a multi-panel with a series of scans/photographs in order to support the message presented in the narrative.
• Please remember to carefully follow the in this type of publication.
• The submitted manuscript should be a maximum of 250 words for the main body of the text, references excluded. A maximum of five references can be included.
• There is no formal structure on this type of manuscript.
• Abstracts are not included.

Case Reports

• These are short case reports including current literature reviews.
• The submitted manuscript should be no longer than 2000 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends). A maximum of 30 references can be included.
• Manuscripts should consist of the following sections:
  • Introduction: This section should give a brief overview of the problem that the case addresses and include a summary of the relevant literature related to the case. The introduction should end with a single sentence describing the patient and the basic condition that he or she suffers from.
  • Case Presentation: This section should include relevant demographic details such as background information about the patient, medical history, details of the patient's symptoms, physical examination, and laboratory/imaging results, the confirmed diagnosis and the course of treatment or intervention, management, and clinical outcome.
  • Discussion: This section should expand on what has been said in the introduction, focusing on why the case is noteworthy and the problem that it addresses.

This should be followed by a summary of the existing literature on the topic that describes the existing theories and research findings on the key issue in the patient's condition. The review should narrow down to the source of confusion or the main challenge in the case.

Finally, the case report should connect to the existing literature, mentioning the message that the case conveys. The author should explain whether this corroborates with or detracts from current beliefs about the problem and how this evidence can add value to future clinical practice.

• Conclusion: This section should concisely conclude the findings of your study.
• An abstract can be included (a maximum of 150 words) but is not compulsory.
• We recommend authors to use the CARE Reporting Guideline for their study. A completed CARE checklist should be included during submission.

Letters to the Editor

• Letters to the Editor that comment on anything within the Journal can be submitted for publication.
• There is no formal structure on this type of manuscript.
• The submissions should be a maximum of 1000 words and can include a maximum of ten references.
• Abstracts are not included.

EVTM-ST Section

• Content in this section is published as part of the regular journal issues and is curated by the EVTM-ST Senior Editor.
• The EVTM-ST Section is designed to support resident and fellow education. For each issue, the editors will invite one trainee to submit an educational case report. An invited reviewer will then provide a brief accompanying editorial. EVTM-ST editors do not participate as authors or reviewers for this section.
• The section includes a standard case report accompanied by relevant figures (e.g. CT scans, angiography, or other pertinent imaging). The discussion should conclude with a concise "What I learned" summary or bullet points. The invited reviewer’s short editorial forms the final paragraph of the section.
• Submissions should be no longer than 1500 words for the main body of text (from introduction to conclusion), excluding the abstract, references, tables, and legends). A maximum of 30 references can be included.
• Manuscripts should consist of the following sections:
  • Introduction: This section should give a brief overview of the problem that the case addresses and include a summary of the relevant literature related to the case. The introduction should end with a single sentence describing the patient and the basic condition that he or she suffers from.
  • Case Presentation: This section should include relevant demographic details such as background information about the patient, medical history, details of the patient's symptoms, physical examination, and laboratory/imaging results, the confirmed diagnosis and the course of treatment or intervention, management, and clinical outcome.
  • Discussion: This section should expand on what has been said in the introduction, focusing on why the case is noteworthy and the problem that it addresses.

This should be followed by a summary of the existing literature on the topic that describes the existing theories and research findings on the key issue in the patient's condition. The review should narrow down to the source of confusion or the main challenge in the case.

Finally, the case report should connect to the existing literature, mentioning the message that the case conveys. The author should explain whether this corroborates with or detracts from current beliefs about the problem and how this evidence can add value to future clinical practice.

• Conclusion/Learning Points: This section should concisely conclude the findings of your study and what you learned from it.
• An abstract can be included (a maximum of 150 words) but is not compulsory.
• We recommend authors to use the CARE Reporting Guideline for their study. A completed CARE checklist should be included during submission.

Commentary

• Commentaries that comment on anything within the Journal can be submitted for publication.
• There is no formal structure on this type of manuscript.
• The submissions should be a maximum of 1000 words and can include a maximum of ten references.
• Abstracts are not included.